TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from InhaleRx Limited ( (AU:IRX) ) is now available.
InhaleRx Limited reported a 15.8% increase in its half-year loss, amounting to $854,332 for the period ending June 30, 2025, compared to the previous year’s loss of $737,576. The company did not declare any dividends during this period, and its net tangible assets per ordinary security decreased significantly from (0.03) cents to (0.41) cents, indicating a challenging financial performance.
More about InhaleRx Limited
InhaleRx Limited operates in the healthcare industry, focusing on the development and provision of inhalation-based therapies. The company is dedicated to advancing medical treatments through innovative inhalation technologies.
Average Trading Volume: 267,657
Technical Sentiment Signal: Buy
Current Market Cap: A$7.47M
Learn more about IRX stock on TipRanks’ Stock Analysis page.